The IASLC released guidance on the use of biopsies for the detection of EGFR and other tumor mutations in patients with NSCLC.
from Latest articles from Cancer Therapy Advisor News https://ift.tt/2NBdBuQ
from Latest articles from Cancer Therapy Advisor News https://ift.tt/2NBdBuQ